Neurochemistry Laboratory, Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India,
Neurochem Res. 2013 Oct;38(10):2009-18. doi: 10.1007/s11064-013-1107-z. Epub 2013 Jul 12.
The neuromuscular disorder, calpainopathy (LGMD 2A), is a major muscular dystrophy classified under limb girdle muscular dystrophies. Genetic mutations of the enzyme calpain 3 cause LGMD 2A. Calpainopathy is phenotypically observed as progressive muscle wasting and weakness. Pathomechanisms of muscle wasting of calpainopathy remain poorly understood. Oxidative stress, NF-κB and the ubiquitin proteasomal pathway underlie the pathology of several muscle wasting conditions but their role in calpainopathic dystrophy is not known. Oxidative and nitrosative stress, the source of reactive oxygen species, NF-κB signaling and protein ubiquitinylation were studied in 15 calpainopathic and 8 healthy control human muscle biopsies. Oxidative stress and NF-κB/IKK β signaling were increased in calpainopathic muscle and may contribute to increased protein ubiquitinylation and muscle protein loss. Preventing oxidative stress or inhibition of NF-κB signaling could be considered for treatment of LGMD 2A.
神经肌肉疾病,钙蛋白酶病(LGMD2A),是一种主要的肌肉萎缩症,归类于肢带型肌肉营养不良症。酶钙蛋白酶 3 的基因突变导致 LGMD2A。钙蛋白酶病的表型表现为进行性肌肉消瘦和无力。钙蛋白酶病肌肉消瘦的发病机制仍知之甚少。氧化应激、NF-κB 和泛素蛋白酶体途径是几种肌肉消耗疾病的病理学基础,但它们在钙蛋白酶病中的作用尚不清楚。活性氧的来源氧化应激和硝化应激、NF-κB 信号转导和蛋白质泛素化在 15 例钙蛋白酶病和 8 例健康对照的人类肌肉活检中进行了研究。钙蛋白酶病肌肉中的氧化应激和 NF-κB/IKKβ信号转导增加,这可能导致蛋白质泛素化增加和肌肉蛋白丢失。预防氧化应激或抑制 NF-κB 信号转导可考虑用于治疗 LGMD2A。